POLARAMINE Side Effects

6468195-6 | Jaundice, Liver Disorder, Nasopharyngitis, Pyrexia
on Nov 19, 2009 Female patient from JAPAN , 24 years of age, was diagnosed with pruritus and was treated with Polaramine (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), liver disorder, nasopharyngitis, pyrexia. Polaramine dosage: Po. During the same period patient was treated with BETAMETHASONE (Po) (View Betamethasone Review and Betamethasone Label ), ALDIOXA (ALDIOXA) (Po) (View Aldioxa (aldioxa) Review and Aldioxa (aldioxa) Label ), EBASTEL (EBASTINE) (Po) (View Ebastel (ebastine) Review and Ebastel (ebastine) Label ). Patient was hospitalized.

5307610-8 | Interstitial Lung Disease
Patient was taking Polaramine (View Usage). Patient had the following side effects: interstitial lung disease on Apr 13, 2007 from JAPAN Additional patient health information: Female patient , weighting 108.0 lb, was diagnosed with hypersensitivity, disseminated intravascular coagulation, colon cancer and. Polaramine dosage: . During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ), KYTRIL (View Kytril Review and Kytril Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), FOY (View Foy Review and Foy Label ), FLUOROURACIL (408mg/body=300mg/m2 In Bolus Then 2720mg/body=2000mg/m2 As Continuous Infusion.) (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ).

5223659-8 | Dementia
Adverse event was reported on Jan 17, 2007 by a Female patient taking Polaramine (View Usage) (Dosage: 6 Mg) was diagnosed with hepatic cirrhosis and. Location: JAPAN , 65 years of age, After Polaramine was administered, patient had the following side effects: dementia (What is dementia?). During the same period patient was treated with TAVEGYL (2 Mg) (View Tavegyl Review and Tavegyl Label ), BARACLUDE (Unk) (View Baraclude Review and Baraclude Label ), PARIET (20 Mg) (View Pariet Review and Pariet Label ), LIVACT (12.45 G) (View Livact Review and Livact Label ), PENTAZOCINE LACTATE (50 Mg) (View Pentazocine Lactate Review and Pentazocine Lactate Label ).

5207166-4 | Abdominal Pain, Shock
on Jan 02, 2007 Female patient from FRANCE , 54 years of age, was diagnosed with rectosigmoid cancer and was treated with Polaramine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), shock. Polaramine dosage: . During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), RANIPLEX (View Raniplex Review and Raniplex Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ELOXATIN (View Eloxatin Review and Eloxatin Label ), ZOCOR (View Zocor Review and Zocor Label ), ARTEX (View Artex Review and Artex Label ). Patient was hospitalized.


5034356-6 | Abdominal Pain, Cardio-respiratory Arrest, Dyspnoea, Malaise, Shock
on May 19, 2006 Female patient from , 54 years of age, was diagnosed with rectosigmoid cancer and was treated with Polaramine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), cardio-respiratory arrest, dyspnoea, malaise, shock. Polaramine dosage: . During the same period patient was treated with ZOPHREN (View Zophren Review and Zophren Label ), RANIPLEX (View Raniplex Review and Raniplex Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ELOXATIN (View Eloxatin Review and Eloxatin Label ), ZOCOR (View Zocor Review and Zocor Label ), ARTEX (View Artex Review and Artex Label ). Patient was hospitalized.

5011871-2 | Abdominal Pain, Malaise, Shock
Patient was taking Polaramine (View Usage). After Polaramine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), malaise, shock on May 19, 2006 from Additional patient health information: Female patient , 54 years of age, was diagnosed with colon cancer and. Polaramine dosage: . During the same period patient was treated with ZOPHREN (View Zophren Review and Zophren Label ), RANIPLEX (View Raniplex Review and Raniplex Label ), CORTICOIDS (View Corticoids Review and Corticoids Label ), ELOXATIN (View Eloxatin Review and Eloxatin Label ).

4679768-5 | Cerebellar Syndrome, Confusional State, Coordination Abnormal, Depressed Level Of Consciousness, Extensor Plantar Response, Migraine, Neurological Symptom, Urticaria Chronic
Adverse event was reported on May 18, 2005 by a Female patient taking Polaramine (View Usage) (Dosage: 5 Mg) was diagnosed with urticaria, allergenic desensitisation procedure and. Location: , 34 years of age, Patient experienced the following unwanted or unexpected effects: cerebellar syndrome, confusional state, coordination abnormal, depressed level of consciousness, extensor plantar response, migraine (What is migraine?), neurological symptom, urticaria chronic. During the same period patient was treated with METHYLPREDNISOLONE (80 Mg) (View Methylprednisolone Review and Methylprednisolone Label ), AERIOUS (DESLORATADINE) 'LIKE CLARINEX' (5 Mg Qd Oral) (View Aerious (desloratadine) 'like Clarinex' Review and Aerious (desloratadine) 'like Clarinex' Label ), ALLERGENS, INSECT VENOM (View Allergens, Insect Venom Review and Allergens, Insect Venom Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), LAROXYL (View Laroxyl Review and Laroxyl Label ), MEPRONIZINE (View Mepronizine Review and Mepronizine Label ). Patient was hospitalized.

4659061-7 | Colon Cancer, Diarrhoea, Electromyogram Abnormal, Ichthyosis, Malignant Neoplasm Progression, Neuropathy, Rash
on Apr 29, 2005 Male patient from , 78 years of age, weighting 149.9 lb, was diagnosed with metastatic neoplasm and was treated with Polaramine (View Usage). Patient had the following side effects: colon cancer, diarrhoea, electromyogram abnormal, ichthyosis, malignant neoplasm progression, neuropathy, rash (What is rash?). Polaramine dosage: . During the same period patient was treated with AERIUS (DESLORATADINE) (View Aerius (desloratadine) Review and Aerius (desloratadine) Label ), SOLUPRED (View Solupred Review and Solupred Label ), FLOUROURACIL INJECTABLE SOLUTION (3610 Mg Intravenous) (View Flourouracil Injectable Solution Review and Flourouracil Injectable Solution Label ), LEUCOVORIN INJECTABLE (View Leucovorin Injectable Review and Leucovorin Injectable Label ). Patient was hospitalized.